Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis

NCT03402399 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

222

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myelofibrosis, Primary
Myelofibrosis, Post PV
Myelofibrosis, Post ET

Interventions

OTHER: Molecular analysis

Sponsor

Assaf-Harofeh Medical Center